Expert Interview
Discussing Welireg(Belzutifan) as a treatment in patients with von Hippel-Lindau (VHL) disease with associated renal cell carcinoma 1st look
Ticker(s): MRKInstitution: Maimonides Medical Center
- Urologic Oncologist with a focus on kidney, prostate, and bladder cancer
- Treats 5 patients with VHL
Please describe your clinical practice. Roughly how many patients with VHL do you currently manage?
Added By: sara_adminWhat are your thoughts on the use of Welireg and how does it compare to other treatment options?
Added By: sara_adminOn a scale from 1-10 (10 being extremely excited), how would you rate your level of excitement for Welireg?
Added By: sara_adminDo you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
